RecruitingPhase 1NCT04861051
Understanding Ketamine's Dissociative Effects (KD Study)
Understanding Ketamine's Dissociative Effects in Epilepsy (KD Study)
Sponsor
Stanford University
Enrollment
20 participants
Start Date
Jul 26, 2021
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to understand how ketamine brings about dissociative symptoms.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Patient in Stanford Epilepsy Monitoring Unit
- Age >18 years old.
Exclusion Criteria4
- Lifetime psychotic or bipolar disorder
- Inability to speak, read or understand English
- Pregnant or nursing females
- Prior adverse ketamine response
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGKetamine
Study participants will receive 0.5mg/kg of ketamine - one single infusion
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04861051
Related Trials
Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy
NCT025318801 location
Tumor Related Epilepsy
NCT026393251 location
AI-Based Mobile Intervention on Medication Non-Adherence and Transition
NCT074450742 locations
MEHMO Natural History and Biomarkers
NCT060191821 location
Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders
NCT043227342 locations